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Participant-Reported Health Status Predicts Cardiovascular and
All-Cause Mortality Independent of Established and Nontraditional
Biomarkers: Evidence From a Representative US Sample
Steven D. Barger, PhD; Matthew R. Cribbet, PhD; Matthew F. Muldoon, MD, MPH
Background-—Participant-reported health status is a key indicator of cardiovascular health, but its predictive value relative to
traditional and nontraditional risk factors is unknown. We evaluated whether participant-reported health status, as indexed by self-
rated health, predicted cardiovascular disease, and all-cause mortality risk excess of 10-year atherosclerotic cardiovascular
disease (ASCVD) risk scores and 5 nontraditional risk biomarkers.
Methods and Results-—Analyses used prospective observational data from the 1999–2002 National Health and Nutrition
Examination Surveys among those aged 40 to 79 years (N=4677). Vital status was ascertained through 2011, during which there
were 850 deaths, 206 from cardiovascular disease (CVD). We regressed CVD and all-cause mortality on standardized values of self-
rated health in survival models, adjusting for age, sex, education, existing chronic disease, race/ethnicity, ASCVD risk, and
standardized biomarkers (ﬁbrinogen, C-reactive protein [CRP], triglycerides, albumin, and uric acid). In sociodemographically
adjusted models, a 1-SD decrease in self-rated health was associated with increased risk of CVD mortality (hazard ratio [HR], 1.92;
95% CI, 1.51–2.45; P<0.001), and this hazard remained strong after adjusting for ASCVD risk and nontraditional biomarkers (HR,
1.79; 95% CI, 1.42–2.26; P<0.001). Self-rated health also predicted all-cause mortality even after adjustment for ASCVD risk and
nontraditional biomarkers (HR, 1.50; 95% CI, 1.35–1.66; P<0.001).
Conclusions-—Self-rated health provides prognostic information beyond that captured by traditional ASCVD risk assessments and
by nontraditional CVD biomarkers. Consideration of self-rated health in combination with traditional risk factors may facilitate risk
assessment and clinical care. ( J Am Heart Assoc. 2016;5:e003741 doi: 10.1161/JAHA.116.003741)
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C ardiovascular disease (CVD) is the leading cause ofmorbidity and mortality in the United States.1 As a
complement to traditional CVD risk factors, such as smoking
status, hypertension, diabetes mellitus, and cholesterol,
current national guidelines recommend assessment of partic-
ipant-reported health status.2 Participant or self-reported
health status is considered a key indicator of cardiovascular
health,2 predicting morbidity,3,4 and mortality,5,6 above and
beyond traditional and nontraditional risk factors.7–9 In
addition to predicting mortality risk among healthly individ-
uals, self-reported health status remains a robust predictor of
cardiovascular mortality within diseased populations.10 In
2014, CVD risk formulations were updated to more optimally
model the impact of multiple risk factors, now known as the
10-year atherosclerotic cardiovascular disease (ASCVD) risk
calculation. Importantly, this model’s risk prediction is not
duplicated by, or achievable through, consideration of tradi-
tional risk factors individually.11 No studies to date have
evaluated the prognostic value of self-reported health status
relative to current CVD risk formulations.11 Comparisons of
self-reported health status with nontraditional risk factors are
also sparse. Hence, the prognostic value of self-reported
health over optimized consideration of traditional and non-
traditional risk factors together is unknown.
Our objective was to evaluate the prognostic value of
participant-reported health status, as indexed by self-rated
health, for risk of incident cardiovascular and all-cause
mortality after controlling for 10-year ASCVD risk. We also
examined this association after further adjustment for 5
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nontraditional CVD risk factors (ﬁbrinogen, C-reactive protein
[CRP], triglycerides, albumin, and uric acid).12 We evaluated
these associations in a probability sample of US residents
aged 40 to 79 years (N=4677) followed for 9 to 12 years.
Methods
Data Source
We analyzed data from the combined 1999–2002 National
Health and Nutrition Examination Surveys (NHANES), a
representative sample of US residents aged 1 month to
85 years and older.13,14 Participants were interviewed in their
homes and a subset completed a physical examination in a
mobile examination center. Among all participants in the
1999–2002 survey years, 83% of those screened participated
in the interview and 93% of interviewed participants were
examined.15 Examined participants are weighted to represent
the civilian noninstitutionalized US population.15 Current CVD
risk assessment formulae are relevant to adults aged 40 to
79 years of age, so we restricted our analyses to this age
range (N=5701). Participants missing data on ASCVD risk
variables, self-rated health, education (coded less than high
school, high school diploma, some college, or college
graduate or higher) and the other biomarkers reduced the
analytic sample to 4677 (82% of those aged 40–79 who were
examined; Figure 1). All participants provided informed con-
sent, and the study was approved by the National Center for
Health Statistics (NCHS) Ethical Review Board.
Vital Status
Vital status on all participants in this analysis was ascertained
through December 31, 2011 using the National Death
Index.16 Speciﬁc causes of death were classiﬁed using the
10th revision of the International Statistical Classiﬁcation of
Diseases, Injuries, and Causes of Death and these categories
were collapsed into the 10 leading causes of death in the
public use ﬁle. Cardiovascular deaths included combined
deaths from diseases of heart (I00–I09, I11, I13, I20–I51) and
cerebrovascular diseases (I60–I69).
Risk Factors
Traditional CVD risk factors
Blood pressure was measured up to 4 times by trained
personnel using a mercury sphygmomanometer. Blood pres-
sure was deﬁned by the average of values excluding the ﬁrst
reading unless there was only 1 measurement, in which case
Figure 1. Participant selection ﬂow diagram, 1999–2001 National Health and Nutrition
Examination Surveys. ASCVD indicates atherosclerotic cardiovascular disease.
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the single reading was used as the average. Diabetes mellitus
was deﬁned by glucose ≥126 mg/dL or taking insulin.17
Current smoking status was determined by afﬁrmative
answers to both “have you ever smoked at least 100
cigarettes in your life?” and “do you currently smoke?” Total
cholesterol and high-density lipoprotein (HDL) were assessed
at the Johns Hopkins University Lipoprotein Analytical
Laboratory (Baltimore, MD) using standard reference
methods.18,19
ASCVD risk calculation
Ten-year risk for an ASCVD event was derived for each
participant following described methods11,20 and speciﬁcally
used sex- and race-speciﬁc regression coefﬁcients for age,
treated or untreated systolic blood pressure, total and low-
density lipoprotein (LDL) cholesterol, current smoking (yes/
no), and history of diabetes mellitus (yes/no) to calculate
ASCVD risk. Our purpose in calculating ASCVD risk scores
was to optimally partition health risk among our participants
rather than to make treatment decisions. Therefore, we
included ASCVD risk calculations risk for the few participants
with systolic blood pressure higher than 200 mm Hg (N=27)
and with LDL ≥190 mg/dL (N=94); these values are pre-
cluded from online risk calculators. Similarly, we calculated
ASCVD risk for those reporting a past diagnosis of stroke,
heart attack, or other coronary heart disease.
Nontraditional risk biomarkers
NHANES includes a number of laboratory assays. We selected
CRP, ﬁbrinogen, urinary albumin, triglycerides, and uric acid
because they represent 5 of the most studied nontraditional
CVD risk factors.12 Quantitative CRP (sensitive to 0.2 mg/dL)
was assessed with latex enhanced nephlometry using a
Behring Nephelometer. Fibrinogen concentration was assayed
using a STA-Compact (Diagnostica Stago, Inc., Parsippany,
NJ).21,22 Albumin, triglycerides, and uric acid concentrations
were determined with a Hitachi Model 704 multichannel
analyzer (Boehringer Mannheim Diagnostics, Indianapolis,
IN).23,24 NHANES laboratory staff complete comprehensive
laboratory procedure training and formal retraining is con-
ducted annually. Examination protocol ﬁdelity and quality
assurance is monitored regularly during unscheduled evalu-
ations by NCHS staff and contractors.23
Diagnosed Chronic Diseases
Participants were asked whether a doctor or other health
professional ever told them they had had a heart attack, a
stroke, coronary heart disease, congestive heart failure, or
cancer. Diabetes mellitus history is captured in the ASCVD
risk calculation.
Participant Reported Outcome
Self-rated health was assessed by the question, “Would you
say your health in general is excellent, very good, good, fair or
poor?” This global rating reﬂects subjective and objective
perceptions of mental and physical disease burden25 and is
shaped by individual and social characteristics.26,27 We chose
this item because of its importance in population health
surveillance28 (http://www.cdc.gov/hrqol/overview.htm)
and because it complements other assessments, such as
the medical history and laboratory tests.2 This single-item
assessment has comparable predictive validity for mortality
irrespective of wording and when compared to more-complex
multi-item assessments.6,29 We did not evaluate change in
health status over the last year or subjective health questions
that were not assessed across both survey cycles.
Statistical Analysis
Self-rated health (in 5 categories) and biomarkers were
standardized within the analytical sample to provide compa-
rable unit scaling for comparison.30 CRP was log transformed
before standardizing. Thus, unless otherwise noted, all
reported hazard ratios reﬂect a 1-SD change in the predictor.
We used Cox regression to estimate the association between
self-rated health and the 2 mortality outcomes. Participants
who died from non-CVD causes (N=644) were excluded from
CVD mortality analyses. We used participants’ attained age as
the time scale to correctly specify age-dependent mortality
risk31 and also stratiﬁed on 5-year birth cohorts to adjust for
study entry age.32 Models including education and sex as
covariates failed to meet proportional hazards assumptions.
Therefore, education and sex were modeled as stratiﬁcation
variables, an approach that permits adjustment for these
characteristics without explicitly modeling their hazard func-
tions.33,34 We further examined model speciﬁcation by
evaluating squared predicted scores generated from fully
adjusted hazard models. These squared terms were not
statistically signiﬁcant, providing additional evidence of ade-
quately speciﬁed regression models.35
To evaluate the prognostic value of self-rated health, we
entered self-rated health in survival models that cumulatively
adjusted for (1) race/ethnicity and diagnosed chronic
diseases (summed and categorized into 0, 1, 2, or more),
(2) ASCVD risk, and (3) the 5 nontraditional CVD biomarkers.
We also report parallel analyses for each of the 5 biomarkers
(entering self-rated health in the third model) to compare the
prognostic strength of each to self-rated health. Finally, we
report sensitivity analyses for self-rated health restricting the
sample to participants free of baseline CVD as well as
comparisons of categorical self-rated health.
We used StataMP software (version 13.1; Stata Corp LP,
College Station, TX) for all estimates and incorporated
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NHANES clustering, stratiﬁcation, and 4-year exam
weights.15 The analytical sample was identiﬁed with the
subpop option to preserve the integrity of the complex survey
design. CIs that did not include 1.0 were considered
statistically signiﬁcant.
Results
Participant characteristics by vital status are presented in
Table 1. During follow-up, there were 850 deaths (18.2%),
including 206 (5.1%) from CVD.
Table 1. Baseline Characteristics of 1999–2002 NHANES Participants
Characteristic Total Alive Deceased
Participants, n 4677 3827 850
Age y, mean (SE) 55.0 (0.24) 53.5 (0.22) 64.3 (0.46)
Female sex, % (N) 52 (2321) 53 (1982) 45 (339)
Race/ethnicity, % (N)
Mexican American 5 (1122) 5 (933) 4 (189)
Other Hispanic 6 (215) 6 (183) 6 (32)
White (non-Hispanic) 77 (2347) 77 (1920) 77 (427)
Black (non-Hispanic) 9 (871) 9 (683) 11 (188)
Other race 4 (122) 4 (108) 2 (14)
Education level, % (N)
<9th grade 8 (885) 6 (643) 15 (242)
9th–11th grade, no diploma 14 (827) 13 (638) 23 (189)
High school diploma 25 (1010) 25 (838) 25 (172)
Some college 27 (1070) 28 (909) 25 (161)
College graduate or higher 26 (885) 29 (799) 12 (86)
Diagnosed chronic diseases, % (N)
Myocardial infarction 5.0 (270) 3.7 (152) 12.6 (118)
Other coronary heart disease 5.1 (260) 3.7 (152) 13.3 (108)
Congestive heart failure 3.0 (168) 1.8 (78) 10.0 (90)
Stroke 2.9 (174) 1.9 (92) 8.8 (82)
Cancer 7.3 (358) 5.8 (229) 16.3 (129)
Self-rated health, % (N)
Poor 4 (275) 3 (157) 12 (118)
Fair 15 (988) 13 (733) 27 (255)
Good 30 (1493) 29 (1217) 35 (276)
Very good 30 (1160) 32 (1023) 19 (137)
Excellent 20 (761) 22 (697) 8 (64)
Mean (SD) self-rated health 3.24 (1.13) 3.36 (1.11) 2.73 (1.12)
ASCVD risk, % (95% CI)* 8.9 (8.5–9.4) 7.5 (7.1–7.9) 17.8 (17.0–18.7)
Fibrinogen, mg/dL (95% CI) 364 (358–370) 359 (352–365) 396 (388–405)
CRP mg/dL (95% CI) 0.45 (0.42–0.49) 0.42 (0.39–0.46) 0.63 (0.55–0.71)
Triglycerides, mg/dL (95% CI) 160 (151–168) 155 (146–164) 187 (157–218)
Albumin, lg/mL (95% CI) 42.0 (31.8–52.2) 27.6 (17.6–37.7) 129.1 (90.1–168.1)
Uric acid, mg/dL (95% CI) 5.43 (5.37–5.50) 5.37 (5.29–5.44) 5.84 (5.72–5.97)
All values except for mean self-rated health are weighted to represent the civilian noninstitutionalized population ages 40 to 79 years. Some percentages may not sum to 100 because of
rounding. ASCVD indicates atherosclerotic cardiovascular disease; CRP, C-reactive protein; NHANES, National Health and Nutrition Examination Survey.
*Ten-year risk based upon national guidelines.11
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CVD Mortality
In a stratiﬁed model with race/ethnicity and chronic disease
covariates, self-rated health was inversely associated with CVD
mortality (Table 2, CVD mortality, model 1). This association
persisted after further adjusting for ASCVD risk (Table 2, CVD
mortality, model 2) and the 5 nontraditional biomarkers (hazard
ratio [HR], 1.79; 95% CI, 1.42–2.26; Figure 2).36 This fully
adjusted association was observed when analyzing women (HR,
2.31; 95% CI, 1.71–3.11) and men (HR, 1.62; 95% CI, 1.18–
2.23) separately. We repeated the fully adjusted regressions for
participants who did not report a previous diagnosis of stroke,
heart attack, congestive heart failure, or other coronary heart
disease. The inverse association between self-rated health and
CVDmortality risk persisted among participants free of baseline
CVD (HR, 1.67; 95% CI, 1.27–2.18; N=3627; 124 CVD deaths).
Using self-rated health categories referenced to those reporting
very good or excellent heath, CVD mortality for the full sample
was progressively higher for those reporting good (HR, 2.09;
95% CI, 1.15–3.81), fair (HR, 2.72; 95% CI, 1.51–4.90), and poor
health (HR, 6.46; 95% CI, 3.09–13.53).
All-Cause Mortality
Self-rated health showed a similar inverse association with
deaths from all causes. In the stratiﬁed model adjusted for
race/ethnicity and chronic disease, self-rated health was
inversely associated with mortality (HR, 1.58; 95% CI, 1.43–
1.75; N=4677; 850 deaths) and this association persisted
after adjustment for ASCVD risk (Table 2, All-cause mortality,
model 2) and when further adjusting for the 5 nontraditional
biomarkers (HR, 1.50; 95% CI, 1.35–1.66; Figure 2). This fully
adjusted association was observed when analyzing women
(HR, 1.59; 95% CI, 1.36–1.87) and men (HR, 1.45; 95% CI,
1.26–1.66) separately.
This inverse association with all-cause mortality risk was
also observed when restricting participants to those free of
baseline CVD (HR, 1.56; 95% CI, 1.37–1.77; N=4119; 616
events). Using self-rated health categories, all-cause mortality
risk increased in a dose-response manner for those reporting
good (HR, 1.51; 95% CI, 1.15–1.98), fair (HR, 2.34; 95% CI,
1.86–2.94), and poor (HR, 3.16; 95% CI, 2.19–4.55) health
relative to those with very good/excellent health. Biomarkers
and ASCVD risk were strongly stratiﬁed by self-rated health
categories (Table 3). Higher self-rated health was consistently
associated with lower ASCVD risk and more-favorable
nontraditional biomarker concentrations.
Discussion
We evaluated whether self-rated health was associated with
CVD and all-cause mortality in a probability sample of US
adults aged 40 to 79 years of age. Poor self-rated health was
Table 2. CVD and All-Cause Mortality Hazard Ratios (95% CI) for Self-Rated Health and Nontraditional Biomarkers
Variable*
Model 1 Model 2
HR 95% CI P Value HR 95% CI P Value
CVD mortality (N=4033)
Self-rated health 1.92 1.51 to 2.45 <0.001 1.84 1.45 to 2.35 <0.001
Log CRP 1.22 0.97 to 1.52 0.086 1.17 0.92 to 1.50 0.189
Urinary albumin 1.22 1.12 to 1.32 <0.001 1.20 1.11 to 1.30 <0.001
Triglycerides 1.16 1.06 to 1.27 0.002 1.10 1.00 to 1.21 0.056
Uric acid 1.10 0.84 to 1.44 0.475 1.08 0.84 to 1.39 0.522
Fibrinogen 1.52 1.26 to 1.82 <0.001 1.48 1.22 to 1.81 <0.001
All-cause mortality (N=4677)
Self-rated health 1.58 1.43 to 1.75 <0.001 1.54 1.38 to 1.71 <0.001
Log CRP 1.19 1.09 to 1.30 <0.001 1.15 1.06 to 1.26 0.003
Urinary albumin 1.13 1.07 to 1.19 <0.001 1.11 1.05 to 1.17 0.001
Triglycerides 1.13 1.06 to 1.21 0.001 1.08 1.02 to 1.15 0.017
Uric acid 1.11 1.00 to 1.22 0.045 1.10 1.00 to 1.22 0.049
Fibrinogen 1.19 1.08 to 1.30 0.001 1.16 1.06 to 1.28 0.003
Both models stratify on 5-year age cohort, sex, and education. Model 1 includes race/ethnicity and chronic disease as covariates; model 2 also includes 10-year atherosclerotic
cardiovascular disease risk. Each hazard ratio reﬂects a 1-SD change in the predictor. CRP indicates C-reactive protein; CVD, cardiovascular disease.
*Standardized mean=0, standard deviation=1.0.
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associated with a 79% greater risk of CVD mortality and a 50%
greater risk of all-cause mortality after statistically controlling
for ASCVD risk11 and 5 nontraditional biomarkers.12 Self-
rated health had the strongest association with mortality
relative to the nontraditional biomarkers and, in absolute
terms, was large in magnitude. Thus, self-rated health meets
several requirements for a prognostic variable—it is statisti-
cally associated with mortality, is independent of other
established predictors,37,38 and the magnitude of association
is large enough to discount residual confounding.12
This study is the ﬁrst to show that self-rated health
predicts CVD mortality risk beyond that captured in current
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Figure 2. Hazard ratios for cardiovascular and all-cause mortality by self-rated health and
nontraditional biomarkers, National Health and Nutrition Examination Surveys 1999–2002.
Models are simultaneously adjusted for all predictors as well as age, race/ethnicity,
diagnosed chronic disease (heart disease, stroke, and cancer), and 10-year atherosclerotic
cardiovascular disease risk. All predictors are standardized to unit variance. *The CRP
coefﬁcient for cardiovascular disease (CVD) mortality reverses because ﬁbrinogen is
included in this model. CRP and ﬁbrinogen are correlated 0.55 and correlated predictors in
simultaneous regression models can cause a reversal of one of the regression
coefﬁcients.36 CRP is positively associated with CVD mortality risk when excluding
ﬁbrinogen from the model (Table 2). CRP indicates C-reactive protein; SRH, self-rated
health.
Table 3. Nontraditional Biomarkers and ASCVD Risk (95% CI) by Category of Self-Rated Health, NHANES 1999–2002
Variable*
Self-Rated Health (n)
P ValuePoor (275) Fair (988) Good (1493) Very Good (1160) Excellent (761)
Fibrinogen 417 399 to 434 381 373 to 390 371 364 to 378 356 349 to 362 342 331 to 353 <0.001
CRP 0.92 0.68 to 1.16 0.60 0.55 to 0.66 0.49 0.45 to 0.53 0.39 0.35 to 0.43 0.30 0.25 to 0.34 <0.001
Triglycerides 187 164 to 211 178 165 to 192 173 156 to 189 148 135 to 160 138 123 to 152 <0.001
Urinary albumin 206 49 to 363 76 47 to 105 41 22 to 60 21 13 to 29 16 11 to 22 <0.001
Uric acid 5.9 5.6 to 6.3 5.5 5.3 to 5.7 5.6 5.5 to 5.6 5.4 5.3 to 5.5 5.2 5.1 to 5.3 <0.001
ASCVD risk, % 14 13 to 16 11 10 to 12 10 9 to 11 8 7 to 8 6 6 to 7 <0.001
All estimates incorporate the complex survey design. P values were obtained by regressing each variable on self-rated health. ASCVD indicates atherosclerotic cardiovascular disease; CRP,
C-reactive protein; NHANES, National Health and Nutrition Examination Survey.
*Values are mg/dL except for urinary albumin (lg/mL) and ASCVD risk.
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CVD risk formulations. We also show that this predictive
capability is independent of, and generally larger than, a set of
popular nontraditional CVD biomarkers. With the exception of
ﬁbrinogen for CVD mortality, mortality hazards for a 1-SD
change in self-rated health were consistently of larger
magnitude than all other biomarkers for both mortality
outcomes. Our risk estimates for nontraditional biomarkers
are consistent with previous studies12,39; however, the utility
of nontraditional biomarkers for improved risk prediction40
remains controversial.39,41
Unlike laboratory data, self-rated health does not reﬂect a
biological pathway to mortality risk. Instead, we view self-
rated health as an integrated or synthesized summary of
conditions that are on the path.27 That is, the layperson’s
perspective on their health draws upon a knowledge base that
overlaps with, but extends beyond, biomedical assess-
ments.42 Our study provides further support for this view
because both 10-year ASCVD risk and poorer biomarker
status robustly worsen in parallel with poorer self-rated
health. However, adjusting for biomarkers did little to weaken
the association between self-rated health and mortality. This
pattern has been observed elsewhere7,9 and challenges the
notion that self-rated health judgments are necessarily
informed by—and entirely accounted for by—objective
clinical and physiological states.27
No assessment battery perfectly reﬂects health status and
therein lies the advantage of self-rated health—it empirically
captures a wide range of health-relevant domains beyond any
biomarker panel yet available.7,9,43 In addition to single
baseline assessments, trajectories of self-rated health predict
recurrent events within clinical samples, such as myocardial
infarction patients.10 The validity of self-rated health is further
supported by the independence of self-rated health from
extraneous inﬂuences, such as transient moods.44 Beyond its
utility as a global indicator of health risk and health status,
self-rated health is intrinsically valuable as a gold-standard
indicator of health-related quality of life.2,26 Self-rated health
may also improve mortality risk classiﬁcation vis-a-vis ASCVD
risk scores, but evaluating this potential requires a much
larger number of CVD events than observed here.
Strengths of this study include objective assessment of a
number of traditional and nontraditional biomarkers in a
large, diverse representative sample followed for over a
decade. We adopted recommendations to concurrently
evaluate multiple risk factors using standardized scaling for
biomarkers.12 This head-to-head approach provides a less-
biased determination of which risk factors are most impor-
tant12 and shows that self-rated health is among the most
potent indicators of survival over 9 to 12 years. This
taxonomy of the most potent health indicators can help
clinicians identify patients that may beneﬁt from more-
aggressive risk factor management or other clinical
interventions. Another possible application is to include
self-rated health in the primary care examination. Poor health
evaluations could be used to initiate further discussion of
why patients expressing low self-rated health hold that
opinion (ie, family history, other health problems, functional
limitations, etc). Such discussions may unveil information
unknown to the provider and could lead to altered risk factor
interventions. Currently, guidelines for integration of self-
rated health and other patient-reported outcomes into
clinical decision making are poorly developed and represent
an important area for future research.45
This study has several limitations.We lackeddata onnonfatal
CVD outcomes, and we did not examine complementary
participant-reported health domains, such as symptom burden,
functional status, health behaviors, and other diagnostic labels
(eg, arthritis). These theoretically important46 assessments are
associated with self-rated health47–52 and may provide a more-
complete picture of CVD burden.2 We included ASCVD risk as a
covariate in models beyond the context in which they were
developed(ie,extendingtopersonswithexistingCVDatbaseline
and considering nonatherosclerotic causes of death). Nonethe-
less, survival models with ASCVD risk scores are more likely to
accurately reﬂect risk and are more parsimonious relative to
traditional risk factors modeled individually.
In summary, self-rated health had the strongest associa-
tions with CVD mortality risk beyond that captured in current
CVD risk formulations and after accounting for traditional and
nontraditional CVD risk factors. In addition to the predictive
power of self-rated health for CVD mortality, asking patients
about their general health status is exceedingly simple,
inexpensive, and safe to measure. These advantages reinforce
the value of self-rated health as a key metric of cardiovascular
health2 and align with broader national trends to emphasize
patient-centered approaches to the measurement of health
and the delivery of health care.
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